Vertex Newswire

Comprehensive Real-Time News Feed for Vertex.

Results 1 - 20 of 177 in Vertex

  1. New Market Report: Alios BioPharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances ProfileRead the original story

    Sunday | PR-inside.com

    ... uridine nucleotide analog for the treatment of infection from hepatitis C virus (HCV). The company collaborates with Vertex Pharmaceuticals for the develop VX-135. The company also has a number of preclinical programs targeting influenza, rhinovirus ...

    Comment?

  2. Vertex Pharmaceuticals Shares Industry Perspectives with BHCC Students, Faculty, StaffRead the original story

    Saturday Sep 20 | Hispanic Business

    Vertex is one of 15 corporate partners taking part in the College's popular Learn and Earn program, which provides students with paid work experience in prestigious , several scientific fellows and researchers, and others aligned with the mission of supporting STEM education on the company's Annual Day of Service to the community. The Vertex team interacted with more than 400 students and 25 faculty and staff members across business management, marketing, accounting, biotechnology/biological sciences, engineering and computer science programs.

    Comment?

  3. Friday Sector Leaders: Utilities, HealthcareRead the original story w/Photo

    Friday Sep 19 | Forbes.com

    ... holdings of XLU. The next best performing sector is the Healthcare sector, up 0.1%. Among large Healthcare stocks, Vertex Pharmaceuticals, Inc. ( NASD: VRTX ) and Actavis ( NYSE: ACT ) are the most notable, showing a gain of 7.3% and 1.8%, ...

    Comment?

  4. Nasdaq 100 Movers: MU, AMZNRead the original story w/Photo

    Friday Sep 19 | Forbes.com

    ... the year to date performance. Two other components making moves today are Tesla Motors (TSLA), trading down 1.6%, and Vertex Pharmaceuticals (VRTX), trading up 2.0% on the day.

    Comment?

  5. Vertex price target raised to $127 from $103 at Deutsche BankRead the original story

    Friday Sep 5 | Theflyonthewall.com

    Stocks with call strike movement; FSLR VRTX First Solar March 80 call option implied volatility increased 2% to 42, Vertex January 105 call option implied volatility increased 6% to 41 according to IVolatility. Options with increasing implied volatility Options with increasing implied volatility: NPSP GILD VNET AVNR GTAT YHOO RHT VRTX SDRL COV MYL Vertex upgraded to Buy from Neutral at Goldman Goldman Sachs upgraded Vertex Pharmaceuticals to Buy saying it sees a 90% probability of approval for the company's VX-809/Kalydeco combo for cystic fibrosis and a higher likelihood of M&A following the positive Phase 3 data in June.

    Comment?

  6. Vertex Pharmaceuticals Given New $127.00 Price Target at Deutsche BankRead the original story

    Tuesday Sep 16 | AmericanBankingNews.com

    ... firms have also recently commented on VRTX. Analysts at RBC Capital reiterated an "outperform" rating on shares of Vertex Pharmaceuticals in a research note on Wednesday, September 10th. They now have a $120.00 price target on the stock. Separately, ...

    Comment?

  7. Us Stocks-Biotech shares drop, Amarin plunges 20 pctRead the original story

    Friday Sep 12 | Reuters

    ... which largely trades on future growth prospects and such volatile elements as drug pipeline progress - as overvalued. Vertex Pharmaceuticals lost 1.2 percent to $93.10 while Amgen was off 0.9 percent to $137.64 and Regeneron Pharma lost 1 percent to ...

    Comment?

  8. Nasdaq 100 Movers: VRTX, YHOORead the original story w/Photo

    Friday Sep 12 | Forbes.com

    ... Year to date, Yahoo! registers a 3.4% gain. And the worst performing Nasdaq 100 component thus far on the day is Vertex Pharmaceuticals (VRTX), trading down 2.2%. Vertex Pharmaceuticals is showing a gain of 24.1% looking at the year to date ...

    Comment?

  9. Uncertainty Prevails For VertexRead the original story w/Photo

    Thursday Sep 11 | Seeking Alpha

    ... going concern status if the losses continue to occur. Following the successful approval and launch of Incivek, Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) saw its revenue grow overnight in multiple folds in 2011. In no time, the drug crossed ...

    Comment?

  10. Us Stocks-Wall St falls, biotech stocks weakerRead the original story

    Thursday Sep 11 | Reuters

    ... of the day, down 1.3 percent. Celgene Corp was the biggest decliner on the S&P 500, off 3 percent at $91.28, while Vertex Pharmaceuticals was down 2.3 percent at $92.60. Biotechs are a frequent target for profit-taking, as many investors view the ...

    Comment?

  11. Security firm CyberArk's IPO said 'imminent'Read the original story w/Photo

    Thursday Sep 11 | The Times of Israel

    ... include Seed Capital Partners, Cabaret-ArbaOne, Jerusalem Venture Partners (JVP), JP Morgan/Chase Partners and Vertex Venture Capital. In December 2011, CyberArk received a $40 million investment round led by Goldman Sachs and JVP. According to the ...

    Comment?

  12. RBC Capital Reiterates Outperform Rating for Vertex PharmaceuticalsRead the original story

    Wednesday Sep 10 | AmericanBankingNews.com

    ... on the stock. RBC Capital's price objective points to a potential upside of 28.87% from the company's current price. Vertex Pharmaceuticals ( NASDAQ:VRTX ) opened at 93.12 on Wednesday. Vertex Pharmaceuticals has a 1-year low of $58.06 and a 1-year ...

    Comment?

  13. Market Activity, Drug Approval, Upcoming Conference, and Presentation ...Read the original story

    Wednesday Sep 10 | Sys-Con Media

    Today, Analysts Review released its research reports regarding Jazz Pharmaceuticals plc , Keryx Biopharmaceuticals , Vertex Pharmaceuticals Incorporated , WellPoint Inc. and GlaxoSmithKline plc . Private wealth members receive these notes ahead of publication.

    Comment?

  14. Stocks with call strike movement; FSLR VRTXRead the original story

    Sunday Aug 31 | Theflyonthewall.com

    Stocks with call strike movement; FSLR VRTX First Solar March 80 call option implied volatility increased 2% to 42, Vertex January 105 call option implied volatility increased 6% to 41 according to IVolatility. Options with increasing implied volatility Options with increasing implied volatility: NPSP GILD VNET AVNR GTAT YHOO RHT VRTX SDRL COV MYL Vertex upgraded to Buy from Neutral at Goldman Goldman Sachs upgraded Vertex Pharmaceuticals to Buy saying it sees a 90% probability of approval for the company's VX-809/Kalydeco combo for cystic fibrosis and a higher likelihood of M&A following the positive Phase 3 data in June.

    Comment?

  15. Nasdaq 100 Movers: GILD, VRTXRead the original story w/Photo

    Friday Sep 5 | Forbes.com

    ... to our MarketNewsVideo.com website and through our distribution partners. In early trading on Friday, shares of Vertex Pharmaceuticals (VRTX) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.7%. Year to ...

    Comment?

  16. S&P 500 Movers: KORS, VRTXRead the original story w/Photo

    Friday Sep 5 | Forbes.com

    ... to our MarketNewsVideo.com website and through our distribution partners. In early trading on Friday, shares of Vertex Pharmaceuticals (VRTX) topped the list of the day's best performing components of the S&P 500 index, trading up 5.0%. Year to ...

    Comment?

  17. Vertex upgraded to Buy from Neutral at GoldmanRead the original story

    Sunday Aug 31 | Theflyonthewall.com

    Vertex upgraded to Buy from Neutral at Goldman Goldman Sachs upgraded Vertex Pharmaceuticals to Buy saying it sees a 90% probability of approval for the company's VX-809/Kalydeco combo for cystic fibrosis and a higher likelihood of M&A following the positive Phase 3 data in June.

    Comment?

  18. We Now Have the Cure for Hepatitis C, but Can We Afford It?Read the original story w/Photo

    Thursday Sep 4 | Scientific American

    ... known as a protease that the virus depends on to make copies of itself. After several false starts, researchers at Vertex Pharmaceuticals, in collaboration with others, developed a protease inhibitor known as telaprevir, while scientists at ...

    Comment?

  19. Vertex to Present at the Morgan Stanley Global Healthcare Conference on September 10Read the original story

    Tuesday Sep 2 | Business Wire

    Vertex Pharmaceuticals Incorporated today announced that it will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10 at 8:35 a.m. ET.

    Comment?

  20. Biotech's biggest stock gainers and losers this summer in MassachusettsRead the original story w/Photo

    Tuesday Sep 2 | Business Journal

    ... Index's 5.4 percent rise during the same period. The largest three Massachusetts-based biotech firms (Biogen Idec, Vertex Pharmaceuticals and Alnylam Pharmaceuticals) have all seen their shares shoot up by more than 10 percent. Vertex, in ...

    Comment?